The PI3K-Akt pathway transmits signals from GPCRs, regulating downstream targets, such as mTOR, and, thereby, controlling breast cancer cell growth, apoptosis, and drug resistance [19,20,21]. This evidence concerns the gene MTOR and breast carcinoma.